Distinct roles for protease-activated receptors 1 and 2 in vasomotor modulation in rat superior mesenteric artery

被引:25
作者
Kawabata, A
Kubo, S
Nakaya, Y
Ishiki, T
Kuroda, R
Sekiguchi, F
Kawao, N
Nishikawa, H
机构
[1] Kinki Univ, Sch Pharmaceut Sci, Div Physiol & Pathophysiol, Higashiosaka, Osaka 5778502, Japan
[2] Fuso Pharmaceut Ind Ltd, Ctr Res & Dev, Osaka 5368523, Japan
关键词
arteries; nitric oxide; proteases; receptors; vasoconstriction/dilation;
D O I
10.1016/j.cardiores.2003.11.030
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Protease-activated receptors (PARs) 1 and 2 are expressed in various blood vessels including rat aorta, modulating vascular tone. We investigated the roles of PAR-1 and PAR-2 in vasomotor modulation in rat superior mesenteric artery. Methods and results: Effects of the PAR-2-activating peptide Ser-Leu-Ile-Gly-Arg-Leu-amide (SLIGRL-amide) and the PAR-1-activating peptide Thr-Phe-Leu-Leu-Argamide (TFLLR-amide) on isometric tension were examined in isolated rat superior mesenteric artery or aorta. Both SLIGRL-amide and TFLLR-amide caused relaxation in the precontracted rat aortic rings. The latter peptide, but not the former, produced contraction in the resting rings. N-G-nitro-L-arginine methyl ester (L-NAME), but not apamin/charybdotoxin known to block the endothelium-derived hyperpolarizing factor (EDHF) pathway, abolished the relaxation and facilitated the contraction. In the precontracted rat superior mesenteric artery, SLIGRL-amide, but not TFLLR-amide, elicited endothelium-dependent relaxation, which was only partially inhibited by L-NAME with and without indomethacin. The residual relaxation was abolished by apamin/charybdotoxin. Carbenoxolone, a gap junction inhibitor, significantly attenuated the SLIGRL-amide-evoked, EDHF-dependent relaxation, although neither 17-octadecynoic acid, a P450 epoxygenase inhibitor, nor catalase, a hydrogen peroxide scavenger, revealed inhibitory effects. The residual response resistant to carbenoxolone was unaffected by ouabain/BaCl2. In the resting artery, TFLLR-amide, but not SLIGRL-amide, produced only slight contraction, which was dramatically facilitated by combination of L-NAME and apamin/charybdotoxin or by removal of the endothelium. Conclusions: Our data suggest that, in rat superior mesenteric artery, endothelial PAR-2, upon activation, causes relaxation via both NO and EDHF pathways, and that activation of muscular PAR-1 exhibits potential contractile activity that is largely masked by NO and EDHFs pathways triggered by endothelial PAR-1. Gap junctions might be involved in the EDHF mechanisms in this artery. (C) 2004 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:683 / 692
页数:10
相关论文
共 47 条
[1]   An endothelium-derived hyperpolarizing factor distinct from NO and prostacyclin is a major endothelium-dependent vasodilator in resistance vessels of wild-type and endothelial NO synthase knockout mice [J].
Brandes, RP ;
Schmitz-Winnenthal, FH ;
Félétou, M ;
Gödecke, A ;
Huang, PL ;
Vanhoutte, PM ;
Fleming, I ;
Busse, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (17) :9747-9752
[2]   Pharmacological dissection of vascular effects caused by activation of protease-activated receptor 1 and 2 in anesthetized rats [J].
Cicala, C ;
Morello, S ;
Santagada, V ;
Caliendo, G ;
Sorrentino, L ;
Cirino, G .
FASEB JOURNAL, 2001, 15 (06) :1433-+
[4]   Protease-activated receptor-2 (PAR2) in the airways [J].
Cocks, TM ;
Moffatt, JD .
PULMONARY PHARMACOLOGY & THERAPEUTICS, 2001, 14 (03) :183-191
[5]   A protective role for protease-activated receptors in the airways [J].
Cocks, TM ;
Fong, B ;
Chow, JM ;
Anderson, GP ;
Frauman, AG ;
Goldie, RG ;
Henry, PJ ;
Carr, MJ ;
Hamilton, JR ;
Moffatt, JD .
NATURE, 1999, 398 (6723) :156-160
[6]  
Damiano BP, 1999, J PHARMACOL EXP THER, V288, P671
[7]   Analysis of agonist-evoked nitric oxide release from human endothelial cells: Role of superoxide anion [J].
David-Dufilho, M ;
Brunet, A ;
Privat, C ;
Devynck, MA .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2001, 28 (12) :1015-1019
[8]   Potassium does not mimic EDHF in rat mesenteric arteries [J].
Doughty, JM ;
Boyle, JP ;
Langton, PD .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 130 (05) :1174-1182
[9]   EDHF - are there gaps in the pathway? [J].
Edwards, G ;
Weston, AH .
JOURNAL OF PHYSIOLOGY-LONDON, 2001, 531 (02) :299-299
[10]   K+ is an endothelium-derived hyperpolarizing factor in rat arteries [J].
Edwards, G ;
Dora, KA ;
Gardener, MJ ;
Garland, CJ ;
Weston, AH .
NATURE, 1998, 396 (6708) :269-272